tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BOLT Stock Latest News

Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look
Company AnnouncementsBolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look
8d ago
BOLT
Bolt Biotherapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Bolt Biotherapeutics Reports Q3 2024 Financial Results
8d ago
BOLT
Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)
PremiumThe Fly
Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)
9d ago
BOLT
Bolt Biotherapeutics presents updated preclinical data for BDC-4182
PremiumThe Fly
Bolt Biotherapeutics presents updated preclinical data for BDC-4182
15d ago
BOLT
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment
PremiumCompany Announcements
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment
3M ago
8K
BOLT
Bolt Biotherapeutics names Brian O’Callaghan chairman
PremiumThe FlyBolt Biotherapeutics names Brian O’Callaghan chairman
3M ago
BOLT
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
Premium
The Fly
Bolt Biotherapeutics reports Q2 EPS (56c), consensus (48c)
3M ago
BOLT
SunPower, Accenture downgraded: Wall Street’s top analyst calls
Premium
The Fly
SunPower, Accenture downgraded: Wall Street’s top analyst calls
6M ago
PK
SE
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Bolt Biotherapeutics downgraded to Hold from Buy at JonesResearch
6M ago
BOLT
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
PremiumThe Fly
Bolt Biotherapeutics ceases BDC-1001 development, cuts 50% of staff
6M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Bolt Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
6M ago
BOLT
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Bolt Biotherapeutics downgraded to Market Perform from Outperform at Leerink
6M ago
BOLT
Guggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
PremiumThe FlyGuggenheim downgrades Bolt Biotherapeutics on lead candidate discontinuation
6M ago
BOLT
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Bolt Biotherapeutics downgraded to Hold from Buy at Stifel
6M ago
BOLT
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Bolt Biotherapeutics downgraded to Neutral from Buy at Guggenheim
6M ago
BOLT
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
PremiumThe Fly
Bolt Biotherapeutics reports Q1 EPS (28c), consensus (51c)
6M ago
BOLT
Bolt Biotherapeutics Realigns Operations and Leadership Team
PremiumCompany Announcements
Bolt Biotherapeutics Realigns Operations and Leadership Team
6M ago
8K
BOLT
Bolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
PremiumThe Fly
Bolt Biotherapeutics reports Q4 EPS (47c), consensus (48c)
8M ago
BOLT
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
PremiumThe Fly
Bolt Biotherapeutics enrolls first patient in Phase 2 study of BDC-1001
12M ago
BOLT
Bolt Biotherapeutics sees cash funding operations, milestones through 2025
PremiumThe FlyBolt Biotherapeutics sees cash funding operations, milestones through 2025
1y ago
BOLT
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
Premium
The Fly
Bolt Biotherapeutics reports Q3 EPS (43c), consensus (49c)
1y ago
BOLT
Bolt presents updated clinical data from Phase 1 trial of BDC-1002
Premium
The Fly
Bolt presents updated clinical data from Phase 1 trial of BDC-1002
1y ago
BOLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >